Expertise in
7
conditions

Mattias F. Duytschaever

AZ Sint Jan Brugge AV, 
Brugge, VLG, BE 
Expertise in
7
conditions
AZ Sint Jan Brugge AV, 
Brugge, VLG, BE 

Overview

Mattias Duytschaever practices practicing medicine in Brugge, Belgium.

Mr. Duytschaever is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Atrial Tachycardia, Arrhythmias, Pulmonary Vein Stenosis, and Cardiac Ablation.

He is actively involved in clinical research, co-authoring 164 peer reviewed articles and participating in 10 clinical trials.

Gender

Male

Locations

AZ Sint Jan Brugge AV, Brugge, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Identification for the Treatment of Complex Arrhythmias (CartoFinder™ Algorithm Trial: CF163 EU)
Identification for the Treatment of Complex Arrhythmias (CartoFinder™ Algorithm Trial: CF163 EU)
Enrollment Status: Completed
Publish Date: June 15, 2026
Intervention Type: Device
Study Phase: Not Applicable
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
Atrial Fibrillation Progression Trial
Atrial Fibrillation Progression Trial
Enrollment Status: Terminated
Publish Date: February 04, 2025
Intervention Type: Device, Drug
Study Phase: Phase 4
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Enrollment Status: Terminated
Publish Date: June 08, 2023
Intervention Type: Device
Is Ablation of All Inducible Atrial Tachycardias an Appropriate Endpoint During Redo Procedures After Initial Persistent AF Ablation? A Multi-center, Randomised, Single-blind Study
Is Ablation of All Inducible Atrial Tachycardias an Appropriate Endpoint During Redo Procedures After Initial Persistent AF Ablation? A Multi-center, Randomised, Single-blind Study
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Persistent Atrial Fibrillation: a Prospective Multi-centre Randomized Controlled Clinical Study
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Persistent Atrial Fibrillation: a Prospective Multi-centre Randomized Controlled Clinical Study
Enrollment Status: Completed
Publish Date: July 11, 2022
Intervention Type: Drug, Other
Study Phase: Not Applicable
Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation: the POWER-PLUS Study
Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation: the POWER-PLUS Study
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Procedure
Study Phase: Phase 4
'CLOSE'-Guided Pulmonary Vein Isolation as Cure for Paroxysmal Atrial Fibrillation?
'CLOSE'-Guided Pulmonary Vein Isolation as Cure for Paroxysmal Atrial Fibrillation?
Enrollment Status: Completed
Publish Date: June 07, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 8 Less Clinical Trials

164 Total Publications

Evaluating the dual-energy Thermocool SmartTouch SF catheter in the treatment of atrial fibrillation.
Evaluating the dual-energy Thermocool SmartTouch SF catheter in the treatment of atrial fibrillation.
Journal: Future cardiology
Published: August 27, 2026

Frequently Asked Questions about Mattias F. Duytschaever

Is Mattias F. Duytschaever a top-rated expert for Atrial Fibrillation?

MediFind is an objective health platform that identifies experts based on real-world data. Mattias F. Duytschaever is classified as an Elite expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mattias F. Duytschaever participate in research or clinical trials?

Yes. Mattias F. Duytschaever has published 164 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Mattias F. Duytschaever's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Duytschaever's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile